About: Collaborative Neuroscience Network

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Collaborative Neuroscience Network Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

facility in Long Beach, United States

Attributes	Values
rdf:type	Item
description	facility in Long Beach, United States (en)
rdfs:label	Collaborative Neuroscience Network (en)
skos:prefLabel	Collaborative Neuroscience Network (en)
name	Collaborative Neuroscience Network (en)
ROR ID	wds:Q30269674-624D94FC-A83A-4CC1-BADB-E8D3E9583B77
ROR ID	034a8v770
instance of	wds:Q30269674-AC672FF2-5B48-447D-8902-55C108E51C8B
instance of	facility
country	wds:Q30269674-A1131CAF-F5B2-4614-AE8F-C70997258DB8
country	United States of America
Ringgold ID	wds:Q30269674-29A054BC-7920-4885-AF90-8BD98FC37D14
Ringgold ID	90732
inception	wds:Q30269674-13611D49-9CDF-495B-A4BC-91CDF80285FA
inception	2000-01-01 00:00:00Z (xsd:dateTime)
skos:altLabel	CNS (en) CNS Network (en)
located in the adm...erritorial entity	wds:Q30269674-7277B11E-2D1C-401B-B56C-11553A0048A5
ISNI	wds:Q30269674-33AFB82B-99D3-4747-828E-B1D288DF57D0
coordinate location	wds:Q30269674-B6BCB163-B0FF-4688-AB0D-5B0751C355FD
official website	wds:Q30269674-4C935460-4B1F-445D-BD37-D3631D2D3DDD
located in the adm...erritorial entity	Long Beach
ISNI	000000040626519X
coordinate location	POINT(-118.033813 33.777408)
official website	http://www.cnstrial.com/
GRID ID	wds:Q30269674-1E289961-E818-41B0-96FC-D4AD3C36EB52
GRID ID	grid.477096.b
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30269674
is research site of	Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001) Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder Scopolamine in Healthy Volunteers Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder Trial in Adult Subjects With Acute Migraines A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson`s Disease A Study of Paliperidone Palmitate 6-Month Formulation A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression Acute Treatment Trial in Adult Subjects With Migraines Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidep A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome Pediatric Schizophrenia Efficacy and Safety Study Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease. A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adult at Imminent Risk for Suicide Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY) A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study Comparative Bioavailability of Risperidone Assessment of Effect of Rapastinel on Driving Performance Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type Bio-equivalence Study Between SAPHRIS and Asenapine Open Label Safety Study in Acute Treatment of Migraine A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder Study of Rapastinel as Monotherapy in Patients With MDD Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg Daily and 50 mg Daily of REL-1017 in Major Depressive Disorder Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers A Study in Patients With Major Depressive Disorder Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) AGN-241751 in the Treatment of Major Depressive Disorder Study of NSI-189 for Major Depressive Disorder A Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Dose Levels of TAK-831 in Adjunctive Treatment of Adult Participants With Negative Symptoms of Schizophrenia A Clinical Trial Investigating the Efficacy, Safety and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless). A Study of LY3372993 in Participants With Alzheimer's Disease (AD) Eslicarbazepine Acetate Monotherapy Long Term Study Safety and Efficacy in Adult Subjects With Acute Migraines Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software